Ezetimibe CAS:163222-33-1 By ShanghaiChengyu Biotechnology CO., LTD,
Pas encore membre de TradeKey.com? Inscrivez-vous pour vous connecter avec 9 millions d'importateurs et exportateurs. Rejoignez-le maintenant c'est gratuit |
BOOK A CALL
Book Call On Your Favorite Time
Code
🗘

By Signing Up. I agree to TradeKey.com Terms of Use, Privacy Policy, IPR and receive emails related to our services

Contact Us
product
Prev
Ezetimibe CAS:163222-33-1
Next

Ezetimibe CAS:163222-33-1

|

- Minimum Order

Pays:

China

N ° de modèle:

-

Prix FOB:

Localité:

-

Prix de commande minimale:

-

Commande minimale:

-

Packaging Detail:

-

Heure de livraison:

-

Capacité de Fournir:

-

Payment Type:

-

Groupe de produits :

-

Contacter maintenant
Membre gratuit

Personne à contacter Cecilia

Wuhu, Anhui

Contacter maintenant

Spécification du produit

  • Grade Standard: Medicine Grade

La description


Product Name:
Ezetimibe
Synonyms: *-(*-fluorophenyl)**-[*-(*-fluorophenyl)**-hydroxy-propyl]**-(*-hydroxyphenyl)-azetidin**-one;EZETIMIBE;ZETIA;Ezitimibe∬EzetimibeC*4H*1F2N*3;(3R,4S)**-(*-Fluorophenyl)**-[(3S)**-(*-fluorophenyl)**-hydroxypropyl]**-(*-hydroxyphenyl)**-azetidinone, Sch*****5;*-(*-Flurophenyl)-(3R)**-(*-flurophenyl)-(3S)-hydroxypropyl-(4S)-(*-hydroxyphenyl)**-azetidinone;Ezetimide
CAS: **********1
MF: C*4H*1F2NO3
MW: **9.*3
EINECS:  
Mol File: **********1.mol
 

 
Purity:>*9.5% Package:**0g,**0g,1kg,*0kg


Biological Activity of Ezetimibe
Ezetimibe, a cholesterol-absorption inhibitor, reduces levels of low-density lipoprotein (LDL) cholesterol when added to statin treatment.
IC*0 value:
Target: cholesterol-absorption
Ezetimibe is a lipid-lowering drug that inhibits the intestinal absorption of dietary and biliary cholesterol by blocking passage across the intestinal wall. In patients with familial hypercholesterolemia, combined therapy with ezetimibe and simvastatin did not result in a significant difference in changes in intima-media thickness, as compared with simvastatin alone, despite decreases in levels of LDL cholesterol and C-reactive protein. (ClinicalTrials.gov number, NCT*******7.) Ezetimibe offers a new therapeutic option for patients receiving statins who require further reduction in LDL cholesterol.
Chemical Information

M.Wt
**9.*3 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C*4H*1F2NO3
CAS No **********1
Solvent & Solubility
DMSO:*2mg/ml; ethanol:*2mg/ml;
 

Pays: China
N ° de modèle: -
Prix FOB: Obtenir le dernier prix
Localité: -
Prix de commande minimale: -
Commande minimale: -
Packaging Detail: -
Heure de livraison: -
Capacité de Fournir: -
Payment Type: -
Groupe de produits : -

Send a direct inquiry to this supplier

To:

Cecilia < ShanghaiChengyu Biotechnology CO., LTD >

Je veux savoir: